TY - JOUR
T1 - Predicting Late Adverse Events in Uncomplicated Stanford Type B Aortic Dissection
T2 - Results From the ROADMAP Validation Study
AU - Fleischmann, Dominik
AU - Mastrodicasa, Domenico
AU - Willemink, Martin J.
AU - Turner, Valery L.
AU - Hinostroza, Virginia
AU - Burris, Nicholas S.
AU - Yang, Bo
AU - Hanneman, Kate
AU - Ouzounian, Maral
AU - Ocazionez Trujillo, Daniel
AU - Afifi, Rana O.
AU - Estrera, Anthony L.
AU - Lacomis, Joan M.
AU - Sultan, Ibrahim
AU - Gleason, Thomas G.
AU - Pacini, Davide
AU - Folesani, Gianluca
AU - Lovato, Luigi
AU - Stillman, Arthur E.
AU - De Cecco, Carlo N.
AU - Chen, Edward P.
AU - Hinzpeter, Ricarda
AU - Alkadhi, Hatem
AU - Hedgire, Sandeep
AU - Sundt, Thoralf M.
AU - van Kuijk, Sander M. J.
AU - Schurink, Geert Willem H.
AU - Chin, Anne S.
AU - Codari, Marina
AU - Sailer, Anna M.
AU - Mistelbauer, Gabriel
AU - Madani, Mohammad H.
AU - Baeumler, Kathrin
AU - Shen, Jody
AU - Lai, Kendrick M.
AU - Fischbein, Michael P.
AU - Miller, D. Craig
PY - 2025/2/1
Y1 - 2025/2/1
N2 - BACKGROUND: Risk stratification is highly desirable in patients with uncomplicated Stanford type B aortic dissection but inadequately supported by evidence. We sought to validate externally a published prediction model for late adverse events (LAEs), consisting of 1 clinical (connective tissue disease) and 4 imaging variables: maximum aortic diameter, false lumen circumferential angle, false lumen outflow, and number of identifiable intercostal arteries. METHODS: We assembled a retrospective multicenter cohort (ROADMAP [Registry of Aortic Diseases to Model Adverse Events and Progression]) of 401 patients with uncomplicated Stanford type B aortic dissection presenting to 1 of 8 aortic centers between 2001 and 2013, followed until 2020. LAEs were defined as fatal or nonfatal aortic rupture, new refractory hypertension or pain, organ or limb ischemia, aortic aneurysm formation (>= 6 cm), or rapid growth (>= 1 cm per year). We applied the original model parameters to the validation cohort and examined the effect on risk categorization using LAE end points. RESULTS: One hundred and seventy-six patients (44%) with incomplete imaging or clinical data were excluded. Of 225 patients in the final cohort, 90 (40%) developed LAEs, predominantly driven by aneurysm formation. Baseline maximum aortic diameter was significantly larger in patients with (42.6 [95% CI, 39.1-45.8] mm) compared with patients without LAEs (39.9 [95% CI, 36.3-44.2] mm; P=0.001). A multivariable Cox regression model indicated that only maximum diameter was associated with LAEs (hazard ratio, 1.07 [95% CI, 1.03-1.11] per mm; P<0.001), while the other parameters were not (P>0.05). Applying the original prediction model to the validation cohort resulted in a poor 5-year sensitivity (38%) and specificity (69%). CONCLUSIONS: A clinical and imaging-based prediction model performed poorly in the ROADMAP cohort. Maximum aortic diameter remains the strongest predictor of LAEs in uncomplicated Stanford type B aortic dissection.
AB - BACKGROUND: Risk stratification is highly desirable in patients with uncomplicated Stanford type B aortic dissection but inadequately supported by evidence. We sought to validate externally a published prediction model for late adverse events (LAEs), consisting of 1 clinical (connective tissue disease) and 4 imaging variables: maximum aortic diameter, false lumen circumferential angle, false lumen outflow, and number of identifiable intercostal arteries. METHODS: We assembled a retrospective multicenter cohort (ROADMAP [Registry of Aortic Diseases to Model Adverse Events and Progression]) of 401 patients with uncomplicated Stanford type B aortic dissection presenting to 1 of 8 aortic centers between 2001 and 2013, followed until 2020. LAEs were defined as fatal or nonfatal aortic rupture, new refractory hypertension or pain, organ or limb ischemia, aortic aneurysm formation (>= 6 cm), or rapid growth (>= 1 cm per year). We applied the original model parameters to the validation cohort and examined the effect on risk categorization using LAE end points. RESULTS: One hundred and seventy-six patients (44%) with incomplete imaging or clinical data were excluded. Of 225 patients in the final cohort, 90 (40%) developed LAEs, predominantly driven by aneurysm formation. Baseline maximum aortic diameter was significantly larger in patients with (42.6 [95% CI, 39.1-45.8] mm) compared with patients without LAEs (39.9 [95% CI, 36.3-44.2] mm; P=0.001). A multivariable Cox regression model indicated that only maximum diameter was associated with LAEs (hazard ratio, 1.07 [95% CI, 1.03-1.11] per mm; P<0.001), while the other parameters were not (P>0.05). Applying the original prediction model to the validation cohort resulted in a poor 5-year sensitivity (38%) and specificity (69%). CONCLUSIONS: A clinical and imaging-based prediction model performed poorly in the ROADMAP cohort. Maximum aortic diameter remains the strongest predictor of LAEs in uncomplicated Stanford type B aortic dissection.
KW - aneurysm, aortic
KW - aortic dissection
KW - aortic rupture
KW - assessment, risk
KW - computed tomography angiography
KW - hypertension
KW - validation study
KW - FALSE-LUMEN THROMBOSIS
KW - THORACIC SURGEONS
KW - ENTRY TEAR
KW - REPAIR
KW - OUTCOMES
KW - SOCIETY
KW - GROWTH
KW - INTERVENTIONS
KW - ASSOCIATION
KW - DIAGNOSIS
U2 - 10.1161/CIRCIMAGING.124.016766
DO - 10.1161/CIRCIMAGING.124.016766
M3 - Article
SN - 1941-9651
VL - 18
JO - Circulation-Cardiovascular Imaging
JF - Circulation-Cardiovascular Imaging
IS - 2
M1 - e016766
ER -